This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hattori, T. Articles by Kitagawa, M. Search for Related Content PubMed PubMed Citation Articles by Hattori, T. Articles by Kitagawa, M.

Pirh2 Promotes Ubiquitin-Dependent Degradation of the Cyclin-Dependent Kinase Inhibitor p27^Kip1

¹ Department of Biochemistry 1 and ² Second Department of Surgery, Hamamatsu University School of Medicine, Higashi-ku, Hamamatsu, Japan

Requests for reprints: Masatoshi Kitagawa, Department of Biochemistry 1, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu 431-3192, Japan. Phone: 81-53-435-2322; Fax: 81-53-435-2322; E-mail: kitamasa{at}hama-med.ac.jp.

The cyclin-dependent kinase inhibitor p27^Kip1 is degraded in late G₁ phase by the ubiquitin-proteasome pathway, allowing cells to enter S phase. Due to accelerated degradation of p27^Kip1, various human cancers express low levels of p27^Kip1 associated with poor prognosis. S-phase kinase–associated protein 2, the F-box protein component of an SCF ubiquitin ligase complex, is implicated in degradation of p27^Kip1 during S-G₂ phases. Recently, Kip1 ubiquitination–promoting complex has been reported as another ubiquitin ligase that targets cytoplasmic p27^Kip1 exported from the nucleus in G₀-G₁ phases. Here, we identified a RING-H2–type ubiquitin ligase, Pirh2, as a p27^Kip1-interacting protein. Endogenous Pirh2 physically interacted with endogenous p27^Kip1 in mammalian cells. Pirh2 directly ubiquitinated p27^Kip1 in an intact RING finger domain-dependent manner in vivo, as well as in vitro. Ablation of endogenous Pirh2 by small interfering RNA increased the steady-state level of p27^Kip1 and decelerated p27^Kip1 turnover. Depletion of Pirh2 induced accumulation of p27^Kip1 in both the nucleus and cytoplasm. Pirh2 expression was induced from late G₁-S phase, whereas p27^Kip1 was decreased in synchronization with accumulation of Pirh2. Furthermore, reduction of Pirh2 resulted in an impairment of p27^Kip1 degradation and an inhibition of cell cycle progression at G₁-S transition in a p53-independent manner. Overall, the results indicate that Pirh2 acts as a negative regulator of p27^Kip1 function by promoting ubiquitin-dependent proteasomal degradation. [Cancer Res 2007;67(22):10789–95]

This article has been cited by other articles:

				E. Susaki, K. Nakayama, L. Yamasaki, and K. I. Nakayama Common and specific roles of the related CDK inhibitors p27 and p57 revealed by a knock-in mouse model PNAS, March 31, 2009; 106(13): 5192 - 5197. [Abstract] [Full Text] [PDF]

				M. M. Bertagnolli, R. S. Warren, D. Niedzwiecki, E. Mueller, C. C. Compton, M. Redston, M. Hall, H. P. Hahn, S. D. Jewell, R. J. Mayer, et al. p27Kip1 in Stage III Colon Cancer: Implications for Outcome following Adjuvant Chemotherapy in Cancer and Leukemia Group B Protocol 89803 Clin. Cancer Res., March 15, 2009; 15(6): 2116 - 2122. [Abstract] [Full Text] [PDF]